This app assists healthcare professionals in managing heart failure medications. It provides evidence-based algorithms and recommendations for initiating, titrating, and monitoring six common drug classes based on Canadian guidelines.
2.2
May 27, 2020
• Refreshed content to latest (2018) Canadian Cardiovascular Society Heart Failure Guidelines • Added drug class references for: ARNI and Ivabradine • Updated clinical pearls on how to use each drug
MoreMed-HF covers ACEIs/ARBs, Beta-Blockers, Mineralocorticoid Receptor Antagonists (MRA), Angiotensin Receptor Blocker / Neprilysin Inhibitors (ARNI), Ivabradine, and Diuretics.
Med-HF utilizes the 2018 Canadian Cardiovascular Society Heart Failure Guidelines to provide evidence-based algorithms and recommendations.
Currently, Med-HF is supported on iPhone and iPod devices. Information regarding Android availability is not provided.
The latest version of Med-HF is 2.2, which was last updated on May 27, 2020. Further update frequency details are not specified.
Med-HF has an age rating of 12+, making it suitable for a wide range of users in the medical field.
No, Med-HF does not contain advertisements. It is a free application without any in-app purchases or ads.
Med-HF was developed by Alberta Health Services, an organization focused on healthcare delivery and innovation.
In addition to evidence-based algorithms, Med-HF offers dosing information, clinical pearls, references, and a general approach to heart failure management.
